Recurrent fungal keratitis following penetrating keratoplasty: an unusual source of infection.
Maria Elena
ME
Gregory
Elisabeth C A
EC
Macdonald
David
D
Lockington
Kanna
K
Ramaesh
D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002175:Candida / Q000302:isolation & purification*; D002177:Candidiasis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D000077336:Caspofungin; D003320:Corneal Ulcer / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D003607:Dacryocystitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D003907:Dexamethasone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D054714:Echinocandins / Q000627:therapeutic use; D015821:Eye Infections, Fungal / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D006801:Humans; D015948:Keratoplasty, Penetrating; D007765:Lacrimal Apparatus / Q000382:microbiology; D055666:Lipopeptides; D012008:Recurrence; D012086:Reoperation
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D003907:Dexamethasone; D000666:Amphotericin B; D000077336:Caspofungin